Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Predicts Markers of Alzheimer’s Disease

By HospiMedica International staff writers
Posted on 14 Aug 2025

Alzheimer’s disease is linked to the buildup of sticky proteins like amyloid beta and tau in the brain, but current detection methods often require expensive scans or specialized tests. More...

While some blood tests can detect signs of the disease, they cannot pinpoint the exact brain regions affected. Researchers have now developed an artificial intelligence (AI) solution that uses widely available and less costly tests to predict the presence and location of these proteins.

This AI tool, developed by scientists at Boston University Chobanian & Avedisian School of Medicine (Boston, MA, USA), uses brain scans, memory assessments, genetic information, health records, and medical history to detect Alzheimer’s biomarkers. The model was trained on data from seven research cohorts totaling 12,185 participants, learning to identify patterns linked to protein buildup. It was also designed to operate effectively even when some patient data was missing.

The team tested the AI on an independent group of participants not included in the training phase. The results, published in Nature Communications, show that the tool could accurately identify individuals with high amyloid or tau levels. According to the study, this AI tool could streamline patient selection for clinical trials and new drug treatments, enabling faster and more affordable diagnoses.

Additionally, by identifying disease earlier, it could support personalized intervention plans, such as targeted diets or exercise programs to slow disease progression. Researchers believe it may one day be applied to related conditions like frontotemporal dementia and chronic traumatic encephalopathy.

“The tool can help doctors quickly pick people for treatment with new drugs or to participate in research studies, thus saving time and money while reaching more patients who might not have access to costly and complicated tests,” said Vijaya B. Kolachalama, PhD, FAHA, associate professor of medicine and computer science, Boston University. “For the public, this means faster diagnoses, fewer unnecessary exams, and hope for treatments that slow the disease, improving daily life for those affected and their loved ones.”

Related Links:
Chobanian & Avedisian School of Medicine


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.